{"id":"https://openalex.org/W2249128438","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.738","title":"Breast cancer recurrence and related mortality in U.S. pts with early breast cancer","display_name":"Breast cancer recurrence and related mortality in U.S. pts with early breast cancer","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2249128438","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.738","mag":"2249128438"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.738","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.738","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.738","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066855718","display_name":"Lois E. Lamerato","orcid":"https://orcid.org/0000-0001-9955-6444","observed_orcids":["https://orcid.org/0000-0001-9955-6444"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Lamerato","raw_affiliation_strings":["Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062313979","display_name":"Suzanne L Havstad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Havstad","raw_affiliation_strings":["Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Gandhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Gandhi","raw_affiliation_strings":["Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Jones","raw_affiliation_strings":["Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004840750","display_name":"Rowan T. Chlebowski","orcid":"https://orcid.org/0000-0002-4212-6184","observed_orcids":["https://orcid.org/0000-0002-4212-6184"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Chlebowski","raw_affiliation_strings":["Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Detroit, MI; AstraZeneca, Wilmington, DE; AstraZeneca, Macclesfield, United Kingdom; Los Angeles Biomed Research Institute, Torrance, CA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"738","last_page":"738"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.8519999980926514},{"id":"https://openalex.org/keywords/breast-cancer-mortality","display_name":"breast cancer mortality","score":0.8299999833106995},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/distant-recurrence","display_name":"distant recurrence","score":0.8299999833106995},{"id":"https://openalex.org/keywords/locoregional-recurrence","display_name":"locoregional recurrence","score":0.9810000061988831},{"id":"https://openalex.org/keywords/contralateral-breast-cancer","display_name":"contralateral breast cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8809999823570251},{"id":"https://openalex.org/keywords/stage-i-ii-breast-cancer","display_name":"stage I and II breast cancer","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9377326369285583},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6873589158058167},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6545437574386597},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5818737149238586},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.550389289855957},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5152292847633362},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4887661933898926},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4853500425815582},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.47785255312919617},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3892603814601898},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2568773031234741},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.738","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.738","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.738","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4212927645","https://openalex.org/W4220708011","https://openalex.org/W2203649236","https://openalex.org/W2343272991","https://openalex.org/W2896012636","https://openalex.org/W4214594318","https://openalex.org/W2560118851","https://openalex.org/W2044819170","https://openalex.org/W1999504480","https://openalex.org/W3167803280"],"abstract_inverted_index":{"738":[0],"Background:":[1],"An":[2],"understanding":[3],"of":[4,23,43,74,123,148,152,170,243,266,268,299],"the":[5,159,162,167,176,183,247,297],"relationship":[6,31],"between":[7,90,95],"breast":[8],"cancer":[9],"(BC)":[10],"recurrence":[11,91,97,132,164,178,185,202,222,249,255,301],"and":[12,55,76,87,93,99,140,182,199,207,220,226],"mortality":[13,89,214,274,283],"in":[14,246,275,288,312],"pts":[15,45,200,216,276,289,313],"with":[16,50,158,217,238,253,272,277,290,314],"early":[17,51,278,315],"BC":[18,52,263,300],"is":[19,270,284],"important.":[20],"The":[21,189,259],"objective":[22],"this":[24,30],"study,":[25],"therefore,":[26],"was":[27,57,78,203,223,233],"to":[28,84,145,212,295,304],"evaluate":[29],"among":[32],"a":[33,62,100,120,239,306],"mid-western":[34],"health":[35,65],"system":[36],"population.":[37],"Methods:":[38],"A":[39,230],"retrospective":[40],"cohort":[41],"study":[42,153,260],"1616":[44],"(mean":[46],"age":[47],"60":[48],"yrs)":[49],"(stage":[53],"I":[54],"II)":[56],"conducted":[58],"using":[59],"data":[60],"from":[61],"large":[63],"integrated":[64],"care":[66],"system.":[67],"Information":[68],"on":[69,282,310],"demographics,":[70],"disease":[71],"characteristics/treatment,":[72],"evidence/type":[73],"recurrence,":[75,198,264,269],"death":[77,171,245],"obtained.":[79],"Kaplan-Meier":[80],"estimates":[81],"were":[82,111,129,155],"used":[83],"compare":[85],"overall":[86,191],"BC-related":[88,236,244],"types,":[92],"also":[94],"each":[96,106],"type":[98,267],"control":[101],"group":[102,165,179,186,250],"without":[103,201],"recurrence.":[104,292],"For":[105],"comparison,":[107],"hazard":[108],"ratios":[109],"(HR)":[110],"estimated":[112],"after":[113],"controlling":[114],"for":[115,194,215,235],"baseline":[116],"covariates.":[117],"Results:":[118],"During":[119],"median":[121],"follow-up":[122],"44.5":[124],"(range":[125],"6.1\u201398.3)":[126],"months,":[127,228],"there":[128],"192":[130],"(11.9%)":[131],"events":[133],"(26.1%":[134],"loco-regional,":[135,196,219],"15.6%":[136],"contralateral,":[137],"58.3%":[138],"distant)":[139],"188":[141],"(11.6%)":[142],"deaths":[143],"due":[144],"any":[146],"cause,":[147],"which":[149],"85":[150],"(5.3%":[151],"population)":[154],"BC-related.":[156],"Compared":[157],"non-recurrence":[160],"group,":[161],"distant":[163,248,291],"showed":[166],"highest":[168],"risk":[169,242,298],"(HR=13.6,":[172],"p<.001),":[173,181],"followed":[174],"by":[175],"loco-regional":[177,254],"(HR=4.5,":[180],"contralateral":[184,197,221],"(HR=3.0,":[187],"p=.01).":[188],"5-year":[190],"survival":[192,311],"probability":[193],"distant,":[195,218],"41.3%,":[204],"59.3%,":[205],"83.4%,":[206],"91.7%,":[208],"respectively.":[209,229],"Median":[210],"time":[211],"all-cause":[213],"41.2,":[224],"76.9,":[225],"89.5":[227],"similar":[231],"trend":[232],"observed":[234],"mortality,":[237],"significantly":[240],"higher":[241],"vs":[251],"women":[252],"(HR=3.6,":[256],"p<.001).":[257],"Conclusion:":[258],"shows":[261],"that":[262],"irrespective":[265],"associated":[271],"increased":[273],"BC.":[279,316],"This":[280],"effect":[281,309],"substantially":[285],"more":[286],"pronounced":[287],"Therapies":[293],"shown":[294],"reduce":[296],"are":[302],"likely":[303],"have":[305],"significant":[307],"beneficial":[308],"Author":[317],"Disclosure":[318],"Employment":[319],"or":[320,323],"Leadership":[321],"Consultant":[322],"Advisory":[324],"Role":[325],"Stock":[326],"Ownership":[327],"Honoraria":[328],"Research":[329],"Funding":[330],"Expert":[331],"Testimony":[332],"Other":[333],"Remuneration":[334],"AstraZeneca":[335,336,337,338]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}